TRNS
Transcat, Inc. (NASDAQ)
Industrials — Specialty Business Services
Transcat, Inc. provides calibration and laboratory instrument services in the United States, Canada, and internationally. The company operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services. This segment also provides CalTrak, a proprietary document and asset management system that is used to manage the workflow of its calibration service centers and customers' assets; and Compliance, Control, and Cost, an online customer portal that provides its customers with web-based asset management capability, as well as a safe and secure off-site archive of calibration and other service records. The Distribution segment sells and rents test, measurement, and control instruments for customers' test and measurement instrumentation needs, as well as value-added services, such as calibration/certification of equipment purchase, equipment rental, used equipment for sale, and equipment kitting. This segment markets and sells its products through website, digital and print advertising, proactive outbound sales, and an inbound call center. The company provides services and products to highly regulated industries, principally life science, which includes companies in the pharmaceutical, biotechnology, medical device, and other FDA-regulated industries; and additional industries, including aerospace and defense, industrial manufacturing, energy and utilities, oil and gas, chemical manufacturing, and other industries that require accuracy in processes and confirmation of the capabilities of their equipment. Transcat, Inc. was incorporated in 1964 and is headquartered in Rochester, New York.
Price History
Fundamentals
| Market Cap | $865.98M |
| P/E Ratio (TTM) | 162.65 |
| Forward P/E | 43.27 |
| EPS (TTM) | $0.57 |
| Dividend Yield | - |
| Profit Margin | 1.62% |
| Revenue Growth | 15.80% |
| ROE | 1.83% |
| Debt/Equity | 44.33 |
| Recommendation | None |
| Analyst Target | $101.33 |
| Analysts | 3 |
| Indexes | NASDAQ |
Technical Indicators
| RSI (14) | 65.1 |
| Beta | 0.70 |
| SMA 20 | - |
| SMA 40 | - |
| 52-Week High | $94.76 |
| 52-Week Low | $50.23 |
| 50-Day Avg | $82.59 |
| 200-Day Avg | $71.60 |
| Avg Volume | 165.4K |
| Volume | 1.5K |
Performance Analysis
NEUTRALTRNS presents a mixed picture with both positive and negative indicators.
Recent News
Last updated: Jul 02, 2026 13:34 UTC
Back to Screener Export Report